Mar 16, 2023 / 05:00PM GMT
Operator
Ladies and gentlemen, welcome to the AB Science web conference. I will now hand over to Alain Moussy, Co-Founder and CEO of AB Science. Sir, please go ahead.
Alain Moussy - AB Science S.A. - Co-Founder, Chairman, President, CEO, MD & Scientific Director
Thank you. Welcome to our web conference. My name is Alain Moussy. I'm the CEO of AB Science. The topic of today is to present our new platform focused on microtubule destabilizer agent, MDA.
Next slide, please. Along with me, there is a team made of experts from AB Science, namely Professor Olivier Hermine, who is also Co-Founder of AB Science, the Chairman of the Scientific Committee and an expert in Hematology in the Hematology Department of Hospital Necker in Paris. Also with me is Professor Christian Auclair who is Co-Founder as well and member of the Scientific Committee and expert in Onco-pharmacology and Ecole headed CNRS, which is a well-known research center in [France] of excellence. And with me also Laurent Gros, who is our Head of Drug Discovery.
Next slide, please. So as you
AB Science SA Corporate Call Transcript
Mar 16, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers